Structure via PubChem · Public domain (PubChem)
entinostat
Sign in to saveAlso known as MS-275, SNDX-275, N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester, BAY86-5274, MS 275, MS 27-275, BAY 86-5274, MS-27-275
Entinostat, also known as SNDX-275 and MS-275, is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.
In the Vinony graph
Vinony's link graph records 310 inbound references to entinostat, and connects out to valproic acid, sodium phenylbutyrate and tiazofurin.
It is catalogued under topics including 2-Aminophenyl compounds, 3-Pyridyl compounds and Benzamides.
Vinony links it to 7 Wikipedia language editions.
Chemical data
- Formula
- C21H20N4O3
- Molecular weight
- 376.4 g/mol
- IUPAC name
- pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate
- SMILES
- C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3
- InChIKey
- INVTYAOGFAGBOE-UHFFFAOYSA-N
- XLogP
- 2
- Polar surface area
- 106 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 3
- Molecule type
- Small molecule
- Indications
- Hodgkins lymphoma, breast carcinoma, myelodysplastic syndrome, acute myeloid leukemia
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 376.153541
- Has use
- medication
Show 5 more facts
- chemical formula
- C₂₁H₂₀N₄O₃
- canonical SMILES
- C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3
- World Health Organisation international non-proprietary name
- entinostat
- subject has role
- antineoplastic
- Commons category
- Entinostat
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444340516 | ImageFile = Entinostat.svg | ImageClass = skin-invert-image | ImageSize = 260 | PIN = (Pyridin-3-yl)methyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate | OtherNames = SNDX-275; MS-275 |Section1= |Section2= |Section3= | Section5 = }}
Entinostat, also known as SNDX-275 and MS-275, is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.
Excerpted from Wikipedia’s “entinostat” article, available under the CC BY-SA 4.0 licence.